Takeda Pharmaceutical (NYSE: TAK) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.39 by 23.08 percent. This is a 7.69 percent decrease over earnings of $0.52 per share from the same period last year. The company reported quarterly sales of $7.655 billion which beat the analyst consensus estimate of $7.060 billion by 8.42 percent. This is a 0.02 percent decrease over sales of $7.656 billion the same period last year.